» Articles » PMID: 16356827

Mycophenolic Acid-induced Replication Arrest, Differentiation Markers and Cell Death of Androgen-independent Prostate Cancer Cells DU145

Overview
Journal Cancer Lett
Specialty Oncology
Date 2005 Dec 17
PMID 16356827
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Inosine 5'-monophosphate dehydrogenase inhibitors including mycophenolic acid (MPA) are effective inducers of terminal differentiation in a variety of distinct human tumor cell types. Here, we report that MPA also induces such a differentiation in the androgen-independent prostate cancer derived cell line DU145. MPA evoked replication arrest and accumulation of the DU145 cells in the S-phase of the cell cycle. The inhibitor also induced the expression of CD55, clusterin, granulophysin, glucose-regulated protein 78, vasoactive intestinal polypeptide and prostate-specific transglutaminase, which are differentiation markers associated with the phenotype of normal prostate cells. We suggest that inosine 5'-monophosphate dehydrogenase inhibitors, which are already used for the treatment of other diseases, may be used as potential differentiation therapy drugs to control prostate cancer.

Citing Articles

Physicochemical Characterization and In Vitro Activity of Poly(ε-Caprolactone)/Mycophenolic Acid Amorphous Solid Dispersions.

Sanchez-Aguinagalde O, Sanchez-Rexach E, Polo Y, Larranaga A, Lejardi A, Meaurio E Polymers (Basel). 2024; 16(8).

PMID: 38675007 PMC: 11054924. DOI: 10.3390/polym16081088.


Synthesis and Biological Evaluation of Novel Anti-leukemia Proteolysis-Targeting Chimeras in Degradating Inosine Monophosphate Dehydrogenase.

Sohbati H, Amini M, Balalaie S Iran J Pharm Res. 2023; 21(1):e129251.

PMID: 36942064 PMC: 10024327. DOI: 10.5812/ijpr-129251.


Reuse of Molecules for Glioblastoma Therapy.

Koehler A, Karve A, Desai P, Arbiser J, Plas D, Qi X Pharmaceuticals (Basel). 2021; 14(2).

PMID: 33525329 PMC: 7912673. DOI: 10.3390/ph14020099.


Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story.

Naffouje R, Grover P, Yu H, Sendilnathan A, Wolfe K, Majd N Cancers (Basel). 2019; 11(9).

PMID: 31514446 PMC: 6770829. DOI: 10.3390/cancers11091346.


Identifying drug-pathway association pairs based on L-integrative penalized matrix decomposition.

Liu J, Wang D, Zheng C, Gao Y, Wu S, Shang J BMC Syst Biol. 2018; 11(Suppl 6):119.

PMID: 29297378 PMC: 5770056. DOI: 10.1186/s12918-017-0480-7.